Cargando…
Myosteatosis rather than sarcopenia associates with non‐alcoholic steatohepatitis in non‐alcoholic fatty liver disease preclinical models
BACKGROUND: Non‐alcoholic fatty liver (NAFL) disease (NAFLD) is the most common chronic liver disease in the world. While most subjects have ‘inert’ NAFL, a subset will progress to non‐alcoholic steatohepatitis (NASH) and its life‐threatening complications. A substantial body of literature supports...
Autores principales: | Nachit, Maxime, De Rudder, Maxime, Thissen, Jean‐Paul, Schakman, Olivier, Bouzin, Caroline, Horsmans, Yves, Vande Velde, Greetje, Leclercq, Isabelle Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890270/ https://www.ncbi.nlm.nih.gov/pubmed/33244884 http://dx.doi.org/10.1002/jcsm.12646 |
Ejemplares similares
-
Impact of L-ornithine L-aspartate on non-alcoholic steatohepatitis-associated hyperammonemia and muscle alterations
por: Pichon, Camille, et al.
Publicado: (2022) -
Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
por: Gillard, Justine, et al.
Publicado: (2021) -
Rationale of adding muscle volume to muscle fat infiltration in the definition of an adverse muscle composition is unclear
por: Nachit, Maxime, et al.
Publicado: (2021) -
Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis
por: Habig, Gregory, et al.
Publicado: (2021) -
Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity
por: Kim, Hong-Kyu, et al.
Publicado: (2023)